# [Corrected]
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Final rule; correction.
**SUMMARY:**
The Food and Drug Administration (FDA) is correcting a final rule that appeared in the *Federal Register* of October 28, 2003 (68 FR 61342). That document issued a final rule reclassifying arrhythmia detector and alarm devices from class III to class II (special controls). This device is used to monitor an electrocardiogram (ECG) and to produce a visible or audible signal or alarm when an atria or ventricular arrhythmia occurs. The document published with an inadvertent error. This document corrects that error.
**EFFECTIVE DATE:**
March 8, 2004
**FOR FURTHER INFORMATION CONTACT:**
Elias Mallis, Center for Devices and Radiological Health (HFZ-450), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 301-441-8571, ext. 177.
**SUPPLEMENTARY INFORMATION:**
In FR Doc. 03-27115, appearing on page 61342 in the *Federal Register* of Tuesday, October 28, 2003, the following correction is made:
§ 870.5310
On page 61344, in the first column, in § 870.5310 *Automated external defibrillator,* beginning in the seventh line, the parenthetical “(restoring normal hearth rhythm)” is corrected to read “(restoring normal heart rhythm).”
Dated: February 26, 2004.
Beverly Chernaik Rothstein,
Acting Deputy Director for Policy and Regulations, Center for Devices and Radiological Health.